Diabetes drug metformin tested as breast cancer shield
NCT ID NCT01905046
First seen May 01, 2026 · Last updated May 01, 2026
Summary
This study tests whether metformin, a common diabetes drug, can prevent breast cancer in women at high risk. Participants take metformin or a placebo for 12 months. Researchers check breast tissue samples for abnormal cells to see if the drug reduces cancer risk.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOBULAR BREAST CARCINOMA IN SITU are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
City of Hope Comprehensive Cancer Center
Duarte, California, 91010, United States
-
City of Hope South Pasadena
South Pasadena, California, 91030, United States
-
Cotton O'Neil Cancer Center / Stormont Vail Health
Topeka, Kansas, 66606, United States
-
Doctor's Hospital of Laredo
Laredo, Texas, 78041, United States
-
Duke University Medical Center
Durham, North Carolina, 27710, United States
-
Greenville Health System Cancer Institute-Andrews
Greenville, South Carolina, 29601, United States
-
Los Angeles County-USC Medical Center
Los Angeles, California, 90033, United States
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
-
Mount Sinai Hospital
New York, New York, 10029, United States
-
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
New York, New York, 10032, United States
-
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, 43210, United States
-
Prisma Health Cancer Institute - Butternut
Greenville, South Carolina, 29605, United States
-
Prisma Health Cancer Institute - Easley
Easley, South Carolina, 29640, United States
-
Prisma Health Cancer Institute - Eastside
Greenville, South Carolina, 29615, United States
-
Prisma Health Cancer Institute - Faris
Greenville, South Carolina, 29605, United States
-
Prisma Health Cancer Institute - Greer
Greer, South Carolina, 29650, United States
-
Prisma Health Cancer Institute - Seneca
Seneca, South Carolina, 29672, United States
-
Prisma Health Cancer Institute - Spartanburg
Boiling Springs, South Carolina, 29316, United States
-
Prisma Health Greenville Memorial Hospital
Greenville, South Carolina, 29605, United States
-
Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
-
The Christ Hospital
Cincinnati, Ohio, 45219, United States
-
The Community Hospital
Munster, Indiana, 46321, United States
-
USC / Norris Comprehensive Cancer Center
Los Angeles, California, 90033, United States
-
University of Kansas Cancer Center
Kansas City, Kansas, 66160, United States
-
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104, United States
-
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.